Drug Type Degrader-antibody conjugates |
Synonyms |
Target |
Mechanism CCNK modulators(cyclin K modulators), Trop-2 modulators(Tumor-associated calcium signal transducer 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | KR | 18 Jun 2024 | |
Solid tumor | Discovery | KR | 01 Nov 2024 |